RP11-1C1.5 | Uncharacterized protein | | | | | | Not detected |
ANKRD33B | Ankyrin repeat domain 33B | | | | | | Mixed |
DAP | Death-associated protein | | | | | | Expressed in all |
CTNND2 | Catenin (cadherin-associated protein), delta 2 | | | | | | Tissue enriched |
DNAH5 | Dynein, axonemal, heavy chain 5 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
TRIO | Trio Rho guanine nucleotide exchange factor | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
FAM105A | Family with sequence similarity 105, member A | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FAM105B | Family with sequence similarity 105, member B | Enzymes
| | | | | Expressed in all |
ANKH | ANKH inorganic pyrophosphate transport regulator | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
FBXL7 | F-box and leucine-rich repeat protein 7 | Plasma proteins
| | | | | Mixed |
MARCH11 | Membrane-associated ring finger (C3HC4) 11 | Predicted membrane proteins
| | | | | Tissue enriched |
ZNF622 | Zinc finger protein 622 | | | | | | Expressed in all |
FAM134B | Family with sequence similarity 134, member B | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MYO10 | Myosin X | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
BASP1 | Brain abundant, membrane attached signal protein 1 | Cytoskeleton related proteins Plasma proteins Transporters
| | | | | Tissue enhanced |
CDH18 | Cadherin 18, type 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH12 | Cadherin 12, type 2 (N-cadherin 2) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PRDM9 | PR domain containing 9 | Enzymes Transcription factors
| | | | | Tissue enriched |
C5orf17 | Chromosome 5 open reading frame 17 | | | | | | Tissue enhanced |
CDH10 | Cadherin 10, type 2 (T2-cadherin) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH9 | Cadherin 9, type 2 (T1-cadherin) | Predicted membrane proteins
| | | | | Group enriched |
CDH6 | Cadherin 6, type 2, K-cadherin (fetal kidney) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DROSHA | Drosha, ribonuclease type III | Enzymes
| | | | | Expressed in all |
C5orf22 | Chromosome 5 open reading frame 22 | | | | | | Expressed in all |
PDZD2 | PDZ domain containing 2 | | | | | | Mixed |
GOLPH3 | Golgi phosphoprotein 3 (coat-protein) | | | | | | Expressed in all |
MTMR12 | Myotubularin related protein 12 | | | | | | Expressed in all |
ZFR | Zinc finger RNA binding protein | | | | | | Expressed in all |
SUB1 | SUB1 homolog (S. cerevisiae) | Plasma proteins
| | | | | Expressed in all |
NPR3 | Natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) | Predicted membrane proteins
| | | | | Tissue enhanced |
AC026703.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
TARS | Threonyl-tRNA synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
RXFP3 | Relaxin/insulin-like family peptide receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
SLC45A2 | Solute carrier family 45, member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AMACR | Alpha-methylacyl-CoA racemase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
RP11-1084J3.4 | Complement C1q tumor necrosis factor-related protein 3 | | | | | | Tissue enhanced |
C1QTNF3 | C1q and tumor necrosis factor related protein 3 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
RAI14 | Retinoic acid induced 14 | Cytoskeleton related proteins
| | | | | Mixed |
TTC23L | Tetratricopeptide repeat domain 23-like | | | | | | Group enriched |
RAD1 | RAD1 homolog (S. pombe) | Enzymes
| | | | | Expressed in all |
BRIX1 | BRX1, biogenesis of ribosomes, homolog (S. cerevisiae) | Plasma proteins
| | | | | Expressed in all |
DNAJC21 | DnaJ (Hsp40) homolog, subfamily C, member 21 | | | | | | Expressed in all |
AGXT2 | Alanine--glyoxylate aminotransferase 2 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
PRLR | Prolactin receptor | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AC010368.2 | | | | | | | Not detected |
SPEF2 | Sperm flagellar 2 | | | | | | Mixed |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAPSL | Calcyphosine-like | | | | | | Tissue enriched |
UGT3A1 | UDP glycosyltransferase 3 family, polypeptide A1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |